|
Video: What is a Stock Split?
|
|
Salix Pharmaceuticals is a pharmaceutical company engaged in acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a range of gastrointestinal diseases, which are those affecting the digestive tract. Co.'s products include among others, XIFAXAN550® (rifaximin) Tablets, indicated for the reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years and older; XIFAXAN (rifaximin) tablets, indicated for the treatment of patients 12 years of age and older with travelers' diarrhea; and APRISO® (mesalamine) extended-release capsules, indicated for the maintenance of remission of ulcerative colitis. According to our SLXP split history records, SLXP has had 1 split. | |
|
SLXP (SLXP) has 1 split in our SLXP split history database. The split for SLXP took place on July 13, 2004. This was a 3 for 2 split, meaning for each 2 shares of SLXP owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 1500 share position following the split.
When a company such as SLXP splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the SLXP split history from start to finish, an original position size of 1000 shares would have turned into 1500 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SLXP shares, starting with a $10,000 purchase of SLXP, presented on a split-history-adjusted basis factoring in the complete SLXP split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/04/2014 |
|
End date: |
04/01/2015 |
|
Start price/share: |
$140.45 |
|
End price/share: |
$172.81 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
23.04% |
|
Annualized Gain: |
57.21% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$12,304.00 |
|
Years: |
0.40 |
|
|
|
Date |
Ratio |
07/13/2004 | 3 for 2 |
|
|